The potentiation of cell kill by electrochemotherapy was even more pronounced with multiple intramuscular mIL-12 gene electrotransfer, by 5.3 log, resulting in a 43% increase in tumor cures as well as statistically significant prolongation of specific tumor growth delay (Figures 2,3). The gene discussed is SPRR2A; the disease is neoplasm.